Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin

Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin

BackgroundAnti-Thymocyte Globulin (ATG) is commonly used to prevent graft-versus-host disease (GVHD), but the optimal dosage and type of ATG remains to be determined.ObjectiveWe compared retrospectively the safety and efficacy outcomes of allogeneic transplantation using low-dose ATG-Fresenius (15mg...

Full description

Saved in:
Bibliographic Details
Main Authors: Itai Falicovich, Boaz Nachmias, Shlomo Elias, Eran Zimran, Adir Shaulov, Polina Stepensky, Batia Avni, Sigal Grisariu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
ATG Fresenius
ATG thymoglobulin
allogenic bone marrow transplantation
acute GVHD
chronic GVHD
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1526513/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1526513/full

Similar Items